Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Proof of Concept Study of PMX-60056 for the Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

NCT01312935 is registered in ClinicalTrials.gov with PolyMedix, Inc. as lead sponsor.

NCT NCT01312935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01312935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Proof of Concept Study of PMX-60056 for the Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Lead sponsor
PolyMedix, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2011
Completion date
August 31, 2012
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, coronary artery disease (cad), percutaneous coronary intervention